Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NBI-77860
NBI-77860
Neurocrine hits the brakes on its genetic disease drug
Fierce Biotech
Tue, 06/9/15 - 10:16 am
Neurocrine
NBI-77860
congenital adrenal hyperplasia